KAMADA
LIVE

Serial Number

99182288

Owner

Kamada Ltd.

Attorney

Ben Natter

Filing Date

May 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

KAMADA Trademark

Serial Number: 99182288 • Registration: 8269282

KAMADA is a trademark filed by Kamada Ltd. on May 13, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Kamada Ltd.

2 Holzman Street, Science Park
Rehovot 7670402 , IL

Entity Type: 03

Trademark Details

Filing Date

May 13, 2025

Registration Date

May 26, 2026

Published for Opposition

April 7, 2026

Goods & Services

Pharmaceuticals, namely, plasma derived and recombinant immunoglobulins for use in the treatment of infectious diseases, namely, CMV disease, Hepatitis B, Varicella Zoster, and rabies, Hematologic conditions including Idiopathic Thrombocytopenic Purpura; Respiratory conditions including Alpha-1 Antitrypsin Deficiency, Obstetrics and Gynecology conditions such as hemolytic disease of the newborn, Transplantation treatments including solid-organ transplants and hematopoietic stem-cell transplantation; pharmaceuticals namely plasma derived and recombinant proteins for treating pulmonary diseases, congenital Alpha-1 Antitrypsin deficiency, post-exposure prophylaxis against viral infection, preventing and treating immune tolerance based diseases, treating immunological disorders and treating inflammatory diseases; pharmaceuticals namely coagulation factors for bleeding disorders; plasma-derived protein preparations for therapeutic use; vaccines; pharmaceutical preparations for the treatment of lung diseases; pharmaceutical preparations for the treatment or prevention of thromboembolic disorders; pharmaceutical preparations for anesthesia analgesia for surgery; pharmaceutical preparations for treatment of CMV infection and disease; pharmaceutical preparations for the treatment of Varicella Zoster Virus; pharmaceutical preparations for treatment of Hepatitis; pharmaceutical preparations for the treatment of Rabies

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 26, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
May 26, 2026 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 7, 2026 NPUB
PUBLISHED FOR OPPOSITION
Apr 7, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 1, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 11, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 9, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Mar 9, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 18, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 18, 2025 GNSL
SUSPENSION LETTER WRITTEN
Dec 18, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 26, 2025 GNRN
NON-FINAL ACTION E-MAILED
Sep 26, 2025 GNRT
NON-FINAL ACTION WRITTEN
Sep 26, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Sep 23, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
May 13, 2025 MAFR
NEW APPLICATION ENTERED
May 13, 2025 NWAP